ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1. (Q39879394)

15 September 2017

title

ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1. (English)

1 reference

15 September 2017

1

Galit Horn

1 reference

15 September 2017

Nechama I. Smorodinsky

series ordinal

4

object named as

Nechama I Smorodinsky

1 reference

15 September 2017

Avital Gaziel

2

1 reference

15 September 2017

Daniel H Wreschner

series ordinal

3

1 reference

15 September 2017

Marcelo Ehrlich

series ordinal

5

1 reference

15 September 2017

language of work or name

English

0 references

publication date

23 February 2009

1 reference

Experimental Cell Research

15 September 2017

published in

1 reference

15 September 2017

volume

315

1 reference

15 September 2017

issue

8

1 reference

15 September 2017

page(s)

1490-1504

1 reference

The epithelial-mesenchymal transition: new insights in signaling, development, and disease

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial-mesenchymal transitions in development and pathologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Cellular and molecular mechanisms of fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial-mesenchymal transitions: twist in development and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Molecular requirements for epithelial-mesenchymal transition during tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Production and characterization of monoclonal antibodies identifying breast tumor-associated antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitope.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

The MUC1 SEA module is a self-cleaving domain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

The cytoplasmic tail of MUC1: a very busy place

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Interaction of human MUC1 and beta-catenin is regulated by Lck and ZAP-70 in activated Jurkat T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Cell surface-associated mucins in signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

MUC1, the renaissance molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Does a novel form of the breast cancer marker protein, MUC1, act as a receptor molecule that modulates signal transduction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Actin-rich spherical extrusion induced in okadaic acid-treated K562 cells by crosslinking of membrane microdomains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

MUC1 alters oncogenic events and transcription in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

MUC1/X protein immunization enhances cDNA immunization in generating anti-MUC1 alpha/beta junction antibodies that target malignant cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Detection of a secreted MUC1/SEC protein by MUC1 isoform specific monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

A unique mucin immunoenhancing peptide with antitumor properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

MUC1/sec-expressing tumors are rejected in vivo by a T cell-dependent mechanism and secrete high levels of CCL2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Antitumor effects of Mucin 1/sec involves the modulation of urokinase-type plasminogen activator and signal transducer and activator of transcription 1 expression in tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Novel MUC1 splice variants contribute to mucin overexpression in CFTR-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Structure and function of the cell surface (tethered) mucins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial mesenchymal transition traits in human breast cancer cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Restoration of E-cadherin cell-cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Breast tumor cell lines from pleural effusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Establishment and characterization of a cell line of human breast carcinoma origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Regulation of tumor cell motility by ERK mitogen-activated protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1/2 and nuclear factor-kappaB pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

The MAP kinase pathway is required for entry into mitosis and cell survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

The MEK/ERK cascade: from signaling specificity to diverse functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

10.1016/J.YEXCR.2009.02.011

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference